Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fiona Thomson

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Psychopharmacology|September 21, 2013
The relationship between glycine transporter 1 occupancy and the effects of the glycine transporter 1 inhibitor RG1678 or ORG25935 on object retrieval performance in scopolamine impaired rhesus monkeyDonnie Eddins, Terence G Hamill, Vanita Puri, et al.
Investigational New Drugs|May 2, 2026
Hedgehog Inhibitor and Paclitaxel: A Phase I Trial of the Oral Hedgehog inhibitor Taladegib in Combination with Weekly Paclitaxel in Patients with Advanced Solid TumoursRosalind Glasspool, Sarah Patricia Blagden, Michelle Lockley, et al.
Bioorganic & Medicinal Chemistry Letters|May 24, 2011
Identification and optimisation of novel sulfonamide, selective vasopressin V1B receptor antagonistsJames Baker, Matilda Bingham, Ruth Blackburn-Munro, et al.
Molecular Pharmacology|August 23, 2005
Allosteric modulation of the cannabinoid CB1 receptorMartin R Price, Gemma L Baillie, Adèle Thomas, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 2010
The discovery and SAR of indoline-3-carboxamides--a new series of 5-HT6 antagonistsMark Reid, Ian Carlyle, Wilson L Caulfield, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 26, 2020
Pharmacological Characterization of the Novel and Selective <i>α</i>7 Nicotinic Acetylcholine Receptor-Positive Allosteric Modulator BNC375Xiaohai Wang, Christopher Daley, Vanita Gakhar, et al.
Bioorganic & Medicinal Chemistry Letters|April 5, 2011
The discovery of novel 8-azabicyclo[3.2.1]octan-3-yl)-3-(4-chlorophenyl) propanamides as vasopressin V1A receptor antagonistsSusan Napier, Grant Wishart, William Arbuckle, et al.
British Journal of Cancer|December 19, 2025
Correction: Relative telomere length and senescence-associated inflammatory cytokines as blood-based prognostic markers in patients with advanced or resectable gastro-oesophageal adenocarcinomaAlan E Bilsland, Eilidh McCulloch, Sofie Degerman, et al.
British Journal of Cancer|November 17, 2025
Relative telomere length and senescence-associated inflammatory cytokines as blood-based prognostic markers in patients with advanced or resectable gastro-oesophageal adenocarcinomaAlan E Bilsland, Eilidh McCulloch, Sofie Degerman, et al.
ACS Chemical Biology|December 30, 2016
Iterative Focused Screening with Biological Fingerprints Identifies Selective Asc-1 Inhibitors Distinct from Traditional High Throughput ScreeningPeter S Kutchukian, Lee Warren, Brian C Magliaro, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Psychopharmacology|September 21, 2013
The relationship between glycine transporter 1 occupancy and the effects of the glycine transporter 1 inhibitor RG1678 or ORG25935 on object retrieval performance in scopolamine impaired rhesus monkeyDonnie Eddins, Terence G Hamill, Vanita Puri, et al.
Investigational New Drugs|May 2, 2026
Hedgehog Inhibitor and Paclitaxel: A Phase I Trial of the Oral Hedgehog inhibitor Taladegib in Combination with Weekly Paclitaxel in Patients with Advanced Solid TumoursRosalind Glasspool, Sarah Patricia Blagden, Michelle Lockley, et al.
Bioorganic & Medicinal Chemistry Letters|May 24, 2011
Identification and optimisation of novel sulfonamide, selective vasopressin V1B receptor antagonistsJames Baker, Matilda Bingham, Ruth Blackburn-Munro, et al.
Molecular Pharmacology|August 23, 2005
Allosteric modulation of the cannabinoid CB1 receptorMartin R Price, Gemma L Baillie, Adèle Thomas, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 2010
The discovery and SAR of indoline-3-carboxamides--a new series of 5-HT6 antagonistsMark Reid, Ian Carlyle, Wilson L Caulfield, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 26, 2020
Pharmacological Characterization of the Novel and Selective <i>α</i>7 Nicotinic Acetylcholine Receptor-Positive Allosteric Modulator BNC375Xiaohai Wang, Christopher Daley, Vanita Gakhar, et al.
Bioorganic & Medicinal Chemistry Letters|April 5, 2011
The discovery of novel 8-azabicyclo[3.2.1]octan-3-yl)-3-(4-chlorophenyl) propanamides as vasopressin V1A receptor antagonistsSusan Napier, Grant Wishart, William Arbuckle, et al.
British Journal of Cancer|December 19, 2025
Correction: Relative telomere length and senescence-associated inflammatory cytokines as blood-based prognostic markers in patients with advanced or resectable gastro-oesophageal adenocarcinomaAlan E Bilsland, Eilidh McCulloch, Sofie Degerman, et al.
British Journal of Cancer|November 17, 2025
Relative telomere length and senescence-associated inflammatory cytokines as blood-based prognostic markers in patients with advanced or resectable gastro-oesophageal adenocarcinomaAlan E Bilsland, Eilidh McCulloch, Sofie Degerman, et al.
ACS Chemical Biology|December 30, 2016
Iterative Focused Screening with Biological Fingerprints Identifies Selective Asc-1 Inhibitors Distinct from Traditional High Throughput ScreeningPeter S Kutchukian, Lee Warren, Brian C Magliaro, et al.
Pageof 4